$Viking Therap(VKTX.US) | ๐๐ข๐ค๐ข๐ง๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ: Raymond James reiterates ๐๐ญ๐ซ๐จ๐ง๐ ๐๐ฎ๐ฒ, maintains ๐๐ ๐๐ญ $๐๐๐
Analyst sees GLP-1/GIP data readthrough as neutral-to-positive, with no meaningful LBM disadvantage and stronger weight loss profile supporting VKTX outlook.Source: Hardik Shah
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments